Valuation · at the close on 16 Oct 2026

IBL HealthCare Limited (IBLHL) valuation

At Rs 41.37 (close on 16 Oct 2026) IBLHL trades at 18.5× earnings (FY2026), below its five-year average of 99.3× and above the Pharmaceuticals median of 12.5×.

P/E · today

18.5×

FY2026

5-yr average99.3× Sector median12.5×

P/B · today

—

FY2026

5-yr average— Sector median3.14×

EV/EBITDA · today

—

5-yr average— Sector median6.7×

Dividend yield · today

—

FY2026

5-yr average— Payers' median4.6%

Market value — at Rs 41.37. Sector medians use the latest close of 14 Pharmaceuticals companies; P/E and P/B only where earnings / book value are positive; the yield median covers dividend payers only. Not investment advice.

Valuation history

At each fiscal year-end price.

5 10 All

IBLHL valuation history (annual) (Rs bn)

Rs bn	FY2026 Jul 2025 – Jun 2026	FY2025 Jul 2024 – Jun 2025	FY2024 Jul 2023 – Jun 2024	FY2023 Jul 2022 – Jun 2023	FY2022 Jul 2021 – Jun 2022	FY2021 Jul 2020 – Jun 2021	FY2020 Jul 2019 – Jun 2020	FY2019 Jul 2018 – Jun 2019	FY2018 Jul 2017 – Jun 2018	FY2017 Jul 2016 – Jun 2017	FY2016 Jul 2015 – Jun 2016	FY2015 Jul 2014 – Jun 2015	FY2014 Jul 2013 – Jun 2014	FY2013 Jul 2012 – Jun 2013	FY2012 Jul 2011 – Jun 2012	FY2011 Jul 2010 – Jun 2011
Market capitalisation	5.2	53.6	2.6	2.3	3.4	6.0	4.2	1.8	4.3	6.0	6.8	4.4	2.5	1.0	0.4	0.2
Enterprise value	4.5	53.6	2.3	2.5	3.5	6.2	4.3	1.9	4.3	5.8	6.7	4.3	2.4	1.0	0.4	0.3
Share price (period end) Rs	53.02	54.43	26.88	23.59	34.25	61.01	42.52	18.39	44.04	60.89	68.92	34.92	20.26	8.04	3.47	1.56
P/E (diluted)	—	25.76×	350.52×	7.52×	13.37×	20.00×	19.04×	14.93×	29.06×	30.23×	37.49×	20.58×	13.29×	7.80×	4.32×	4.17×
Price to book	—	2.31×	1.25×	1.10×	2.17×	3.72×	2.95×	1.44×	3.65×	5.51×	7.28×	5.13×	2.92×	1.69×	1.05×	0.65×
Price to sales	—	1.24×	0.73×	0.58×	1.11×	2.00×	1.57×	1.14×	3.19×	5.04×	5.80×	3.66×	2.17×	0.91×	0.47×	0.30×
EV / EBITDA	—	118.33×	15.24×	3.95×	5.98×	13.80×	12.16×	9.40×	19.77×	22.42×	31.48×	21.88×	13.31×	7.61×	3.86×	3.65×
EV / Sales	0.98×	12.40×	0.64×	0.63×	0.97×	2.06×	1.63×	1.23×	3.13×	4.89×	5.77×	4.60×	2.64×	1.12×	0.57×	0.40×
Dividend yield (gross)	—	0.0%	0.0%	3.1%	1.6%	1.8%	1.3%	3.0%	1.1%	0.7%	0.9%	0.7%	1.5%	5.1%	11.8%	0.0%
Free cash flow yield	—	(5.2%)	21.4%	1.0%	1.4%	1.1%	0.9%	(0.0%)	1.3%	1.6%	1.5%	5.6%	3.5%	7.2%	36.5%	(49.1%)
PEG ratio	—	0.01×	(3.59×)	0.33×	(0.84×)	0.55×	0.23×	(0.80×)	(1.17×)	3.17×	4.50×	1.82×	0.28×	0.27×	0.04×	—
P/E (diluted, normalised)	—	25.76×	350.52×	7.52×	13.34×	20.02×	19.06×	14.93×	29.06×	30.23×	37.49×	20.58×	13.29×	7.80×	4.32×	4.17×
Price to book — 5-year average	—	2.03×	2.10×	2.23×	2.80×	3.40×	3.93×	4.36×	4.94×	4.95×	4.34×	2.82×	—	—	—	—
EV / EBITDA — 5-year average	—	29.85×	8.63×	8.26×	11.14×	15.16×	18.41×	21.09×	22.04×	20.66×	17.92×	12.24×	—	—	—	—
Dividend yield — 5-year average	—	1.2%	1.6%	1.9%	1.6%	1.4%	1.1%	1.0%	0.9%	1.0%	1.5%	2.0%	—	—	—	—

IBLHL valuation: frequently asked questions

What is IBLHL's P/E ratio? +

At the closing price of Rs 41.37 on 16 Oct 2026, IBLHL trades at a P/E of 18.5× based on EPS of Rs 2.24 (FY2026).

Information only, not investment advice.